Present and Future Therapies of Articular Cartilage Defects

Abstract

Background: Until today, no universally successful therapy to treat substantial articular cartilage defects has been available. Numerous therapeutic approaches can only improve clinical symptoms of joint lesions, but cannot stimulate the regenerative and reactive capacity of the biological tissue in the defect, and, thus, cannot restore an articular surface capable of functional load bearing. Some other therapeutic options promised impressing results at the beginning, but did not withstand the process of a closer investigation. Even after laborious, invasive and expensive therapies, patients still complain about pain, joint effusions, restricted movement, or articular blockage.

Established and Novel Therapies: The aim of all therapeutic procedures to treat patients with damaged articular cartilage is to reconstruct the integrity of the articular cartilage surface in order to enable them to live an unrestricted painless professional and private life. This article gives an overview of the clinically established procedures, their indications and the present long-term results, as well as a crucial look on the limitations of each approach. Novel therapies, which integrate molecular biology techniques and tissue engineering into transplantation surgery, are introduced and analyzed in terms of their capability and future potential.